Making Science Group (FRA:MS7) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MS7 Making Science Group SA FRA:MS7
67 GF Score
Price €6.50
GF Value €12.01
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Making Science Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Making Science Group is: High Risk: High uncertainty with risk-return tradeoff.

Making Science Group  (FRA:MS7) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Making Science Group Risk Assessment Related Terms

FRA:MS7 vs APP, OMC, TTD: Risk Assessment Comparison

For the Advertising Agencies subindustry, Making Science Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Making Science Group Risk Assessment vs Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Making Science Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Making Science Group's Risk Assessment falls into.


FRA:MS7
67GF Score
Making Science Group SA FRA:MS7
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Making Science Group (FRA:MS7) Overvalued in 2026?

Based on GuruFocus' analysis, Making Science Group stock appears to be undervalued. The current stock price of €6.50 is trading 45.9% below its estimated GF Value™ of €12.01. GuruFocus considers Making Science Group to be Significantly Undervalued.

Key valuation signals for FRA:MS7:

  • Risk Assessment:
  • GF Value™: €12.01 vs. price of €6.50 (45.9% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the FRA:MS7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Making Science Group Business Description

Other Exchanges ALMKS:FranceMAKS:Spain
Address Calle Lopez de Hoyos 135, Madrid, ESP, 28002
Making Science Group SA is engaged in the business of technology and marketing solutions for the e-commerce and digital transformation business. The company provides solutions in the areas of digital marketing, data analytics, e-commerce, and cloud. The company carries out its professional activity in the United States, Spain, Italy, France, and other. The company obtains its income mainly from advertising and public relations services. The business segments are: Spain; International; and E-commerce and Product. The Spain and International segments, the business lines are Media and Digital Marketing, Cloud Solutions, Software & Cybersecurity, and proprietary Adtech technology. The E-commerce and Product segment focuses on the Marketplace and E-commerce business lines.
67GF Score

Get the complete analysis for FRA:MS7

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.50
Price
€12.01
GF Value